Carol Feghali-Bostwick to Angiogenesis Inhibitors
This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Angiogenesis Inhibitors.
Connection Strength
0.580
-
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model. Int Immunopharmacol. 2015 Oct; 28(2):1102-5.
Score: 0.480
-
Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-. Nihon Rinsho Meneki Gakkai Kaishi. 2013; 36(6):452-8.
Score: 0.100